Cargando…
Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 2021
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352401/ https://www.ncbi.nlm.nih.gov/pubmed/35934226 http://dx.doi.org/10.1016/j.tracli.2022.08.002 |
| _version_ | 1784762642849595392 |
|---|---|
| author | Gallian, Pierre Slimani, Ahmed Malard, Lucile Morel, Pascal de Lamballerie, Xavier |
| author_facet | Gallian, Pierre Slimani, Ahmed Malard, Lucile Morel, Pascal de Lamballerie, Xavier |
| author_sort | Gallian, Pierre |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9352401 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93524012022-08-05 Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 2021 Gallian, Pierre Slimani, Ahmed Malard, Lucile Morel, Pascal de Lamballerie, Xavier Transfus Clin Biol Lettre À La Rédaction Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. 2023-02 2022-08-05 /pmc/articles/PMC9352401/ /pubmed/35934226 http://dx.doi.org/10.1016/j.tracli.2022.08.002 Text en © 2022 Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Lettre À La Rédaction Gallian, Pierre Slimani, Ahmed Malard, Lucile Morel, Pascal de Lamballerie, Xavier Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 2021 |
| title | Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 2021 |
| title_full | Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 2021 |
| title_fullStr | Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 2021 |
| title_full_unstemmed | Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 2021 |
| title_short | Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 2021 |
| title_sort | impact of vaccination on sars-cov-2 seroprevalence rate in french blood donors: an assessment as of july 2021 |
| topic | Lettre À La Rédaction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352401/ https://www.ncbi.nlm.nih.gov/pubmed/35934226 http://dx.doi.org/10.1016/j.tracli.2022.08.002 |
| work_keys_str_mv | AT gallianpierre impactofvaccinationonsarscov2seroprevalencerateinfrenchblooddonorsanassessmentasofjuly2021 AT slimaniahmed impactofvaccinationonsarscov2seroprevalencerateinfrenchblooddonorsanassessmentasofjuly2021 AT malardlucile impactofvaccinationonsarscov2seroprevalencerateinfrenchblooddonorsanassessmentasofjuly2021 AT morelpascal impactofvaccinationonsarscov2seroprevalencerateinfrenchblooddonorsanassessmentasofjuly2021 AT delamballeriexavier impactofvaccinationonsarscov2seroprevalencerateinfrenchblooddonorsanassessmentasofjuly2021 |